•
Mar 31, 2024

Ascendis Pharma Q1 2024 Earnings Report

Total Revenue
$104M
Previous year: $36M
+188.7%
EPS
-$2.5
Previous year: -$2.13
+17.4%
Gross Profit
$91.9M
Cash and Equivalents
$346M
Free Cash Flow
-$110M
Total Assets
$867M

Ascendis Pharma

Ascendis Pharma